On-line Webcast Discusses Chronic Lymphocytic Leukemia

OSUWexnerbloglogo2014 On-line Webcast Discusses Chronic Lymphocytic Leukemia. On this CME webcast, we’re going to bring you up to date on the latest about chronic lymphocytic leukemia, or CLL. Joining us is hematologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Kerry Rogers. And also hematologist and Associate Professor of Internal Medicine from OSU and the James Cancer Hospital, Dr. Jennifer Woyach.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: CLL is a chronic lymphoid malignancy which does not need treatment at diagnosis if asymptomatic and has a survival of many years; CLL patients are at higher risk for second cancers or infection so it is important so all CLL patients with CLL should get all age appropriate cancer screenings and vaccinations; UNDERSTAND indications for treatment in CLL and the rationale for the watch and wait approach; and UNDERSTAND some serious side effects that can occur with oral targeted therapies in CLL.

You’ll also learn about the following:

  • Risks for CLL
  • Current approach to treatment of CLL
  • Roles and limitations of automated WBC differentials
  • Initial approach to lymphocytosis
  • Emerging trends in first line treatment of CLL
  • Role of age of the patient in therapeutic decision making
  • Stem cell transplants

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line CME Education Discusses Lymphoma

OSUWexnerbloglogo2014 On-line CME Education Discusses Lymphoma. Today, Hodgkin’s disease is curable in most patients with a 5-year survival rate of 86%. But this is only one type of lymphoma and as we’ll see today, hematologists have made enormous strides in the management of all types of lymphoma. Joining our moderator are two lymphoma experts from The Ohio State University and the James Cancer Hospital. Dr. Kami Maddocks is an Associate Professor of Internal Medicine from the Division of Hematology. And Dr. Beth Christian is also a hematologist and Associate Professor of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DEFINE the most common types of aggressive lymphomas, identify both urgent initial presentations and urgent complications of treatment, and outline standards of survivorship; and DESCRIBE the features of indolent non-Hodgkin lymphoma including the most common subtypes, follicular lymphoma, marginal zone lymphoma and Waldenström macroglobulinemia.

You’ll also learn about the following:

  • What causes lymphoma
  • The spectrum of lymphomas
  • Stem cell transplant in aggressive lymphomas
  • Whether there a role for “maintenance rituximab”
  • Chronic lymphocytic leukemia versus non-Hodgkin lymphoma
  • Lymphoma mimics
  • Deciding when to biopsy an enlarged lymph node

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Discusses Acute and Chronic Myeloid Leukemia

OSUWexnerbloglogo2014CME Webcast Discusses Acute and Chronic Myeloid Leukemia. Joining our webcast to tell you all about the newest developments in chronic myelogenous leukemia is hematologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Katherine Walsh. And then to tell you about acute myeloid leukemia is OSU hematologist and also Assistant Professor of Internal Medicine, Dr. Alice Mims.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW the clinical presentation and diagnosis of CML; REVIEW the front line treatment options and milestones for response to treatment; DESCRIBE the clinical presentation and diagnosis of AML.

You’ll also learn about the following:

  • Presenting signs and symptoms of CML
  • Presenting signs and symptoms of AML
  • Stem cell transplant in CML
  • Initial evaluation and management of patients with suspected AML
  • Initial treatment of patients with AML
  • CML blast crisis
  • Leukemoid reaction versus CML
  • Which patients with AML require a lumbar puncture
  • Which patients with AML need a permanent venous catheter

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.